Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2941 to 2955 of 7685 results

  1. Board expenses

    Details of the business expenses incurred by the board and senior management team in delivery of their duties. We hold board meetings around the...

  2. Apply to be a chair on a NICE committee

    We're looking for healthcare professionals and lay people to chair our guideline committees.

  3. Committee A members

    Biographies and registered interests for members of the Technology Appraisal Committee A

  4. Accreditation

    NICE guidance accredited decisions - status and term dates of NICE accredited guidance producers.

  5. Committee B members

    Find out more about the NICE technology appraisal advisory committee B members and their registered interests

  6. Committee C members

    Find out more about the committee members by reading their biographies. Prof Stephen G O'Brien BSc (Hons) PhD MBChB FRCP MRCPath (chair) Biography

  7. Committee D members

    Find out more about NICE technology appraisals advisory committee D members

  8. Overview: how we develop technology appraisal guidance

    1. Provisional appraisal topics chosen The NICE topic selection programme produces a list of provisional appraisal topics. 2. Stakeholders identified

  9. Developing NICE guidelines: the manual (PMG20)

    This manual explains the processes and methods used to develop and update NICE guidelines, the guidance that NICE develops covering topics across clinical care (in primary, secondary and community care settings), social care and public health. For more information on the other types of NICE guidance and advice (including technology appraisal guidance), see about NICE

  10. Diabetes: suspended from retinal screening (IND70)

    This indicator covers the proportion of eligible people with diabetes who are suspended from diabetic eye screening due to previous screening results. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as CCG89

  11. Public board meeting agenda and papers: May 2024

    Agenda and papers of the NICE public board meeting on 15 May 2024

  12. Public board meeting agenda and papers: December 2023

    Agenda and papers of the NICE public board meeting on 13 December 2023

  13. Modern slavery and human trafficking statement

    Read NICE's statement on modern slavery and human trafficking

  14. Corporate publications

    Links to our annual reports and business plan

  15. Our role in the Innovative Licensing and Access Pathway (ILAP)

    The Innovative Licensing and Access Pathway (ILAP) aims to streamline patient access to safe, financially sustainable and innovative medicines.